In situ inhibition of uterine activity by indomethacin: Possible relevance to preterm labor prevention after fetal surgery

Journal of Pediatric Surgery

Volumn 39, Issue 8, 2004, Pages 1173-1175

  Garza, Jennifer ^a,b,c   Clayton, Nicholas ^a,b,c   Kaviani, Amir ^a,b,c   Maher, Timothy J ^a,b,c   Fauza, Dario ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c Harvard Center for Minimally Invasive Surgery   (United States)

Author keywords

fetal surgery; indomethacin; myometrium; Premature labor; uterus

Indexed keywords

INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; FETUS SURGERY; FORCE TRANSDUCER; IN VITRO STUDY; MULTICHANNEL RECORDER; MYOMETRIUM; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; TISSUE CULTURE; UTERUS CONTRACTION;

ANIMALS; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; FETAL DISEASES; INDOMETHACIN; MYOMETRIUM; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RATS; RATS, WISTAR; TOCOLYTIC AGENTS; UTERINE CONTRACTION;

EID: 3843132858     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2004.04.006     Document Type: Article

References (13)

1. Fauza D.O., Berde C.B., Fishman S.J. Prolonged local myometrial blockade prevents preterm labor after fetal surgery in a leporine model. J Pediatr Surg. 34:1999;540-542
2. Fauza D.O., Kohane D.S., Beewukes E., et al. Local anesthetics inhibit myometrial activity in vitro Possible application on preterm labor prevention and treatment. Fetal Diagn Ther. 18:2003;292-296
3. Garza J.J., Downard C.D., Clayton N., et al. Clostridium botulinum toxin inhibits myometrial activity in vitro Possible application on the prevention of preterm labor after fetal surgery. J Pediatr Surg. 38:2003;511-513
4. Eltze M. Proestrus and metestrus rat uterus, a rapid and simple in vitro method for detecting histamine H2-receptor antagonism. Arz-neimittelforschung. 29:1979;1107-1112
5. Slater D., Dennes W., Sawdy R., et al. Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol. 22:1999;125-130
6. Vermillion S.T., Landen C.N. Prostaglandin inhibitors as tocolytic agents. Semin Perinatol. 25:2001;256-262
7. Chasin M., Langer R. Biodegradable Polymers as Drug Delivery Systems. 1990;Marcel Dekker, New York, NY
8. Mathiowitz E., Langer R. Polyanhydride microspheres as drug carriers I. Hot-melt microencapsulation. J Biomed Mat Res. 5:1987;13-22
9. Lewis D.H. Controlled release of bioactive agents from lactide/glycolide polymers. Chasin M., Langer R. Biodegradable Polymers as Drug Delivery Systems. 1990;1-41 Marcel Dekker, New York, NY
10. Mayberg M.R., Gross A.S., Mathiowitz E., et al. Sustained release of acetylcholine in rat hippocampus using a polyanhydride drug-delivery system. J Biomed Mat Res. 33:1992;331-335
11. Okada H., Doken Y., Ogawa Y., et al. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm Res. 11:1994;1143-1147
12. Curley J., Castillo J., Hotz J., et al. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology. 84:1996;1401-1410
13. Burch R.M., Wise W.C., Halushka P.V. Prostaglandin-independent inhibition of calcium transport by nonsteroidal anti-inflammatory drugs Differential effects of carboxylic acids and piroxicam. J Pharmacol Exp Ther. 227:1983;84-91